Jeffrey M. Rybak

Mutations in <i>TAC1B</i> : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris

Jeffrey M. Rybak, José F. Muñoz, Katherine S. Barker et al. · mBio · 2020 · 188 citations · Full text

Abrogation of Triazole Resistance upon Deletion of <i>CDR1</i> in a Clinical Isolate of <i>Candida auris</i>

Jeffrey M. Rybak, Laura A. Doorley, Andrew T. Nishimoto et al. · Antimicrobial Agents and Chemotherapy · 2019 · 147 citations · Full text

In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris

Jeffrey M. Rybak, Katherine S. Barker, José F. Muñoz et al. · Clinical Microbiology and Infection · 2021 · 114 citations · Full text

Antifungal Agent, Antifungal Agents, Medicine +9

Mutations in <i>hmg1</i> , Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus

Jeffrey M. Rybak, Wenbo Ge, Nathan P. Wiederhold et al. · mBio · 2019 · 112 citations · Full text

Tedizolid Phosphate: a Next-Generation Oxazolidinone

Jeffrey M. Rybak, Karrine D. Roberts · Infectious Diseases and Therapy · 2015 · 77 citations · Full text

Pharmacotherapy, Antimicrobial Chemotherapy, Antibiotic Resistance +17